Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Working With Your National Provider Number

Melesia Tillman, CCP, CPC  |  Issue: May 2008  |  May 1, 2008

Beginning May 23, 2008, all practicing physicians who treat Medicare patients must start billing with a working national provider identifier (NPI). Physician and non-physician providers can make any corrections or changes pertaining to their NPIs by contacting the National Plan and Provider Enumeration System (NPPES) at [email protected], or by visiting the NPPES Web site, http://nppes.cms.hhs.gov.

The following changes should be implemented in rheumatology practices by May 23:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  • Report the NPI in Box 17b on the CMS-1500 form (leave Box 17a blank);
  • Leave blank the shaded portion of Box 24j (where providers are currently report the rendering provider’s PIN) of the CMS-1500 form; and
  • Verify the NPI for all referring physicians when applicable.

There are steps that a rheumatology practice can take if a physician refers a new patient to the practice after May 23 but does not provide his or her NPI. First, the practice should call the referring physician’s office to obtain the NPI. If there is no response to the call, office staff can check the NPI database. In extreme circumstances, CMS gives instruction in Transmittal 235 of the Program Integrity Manual that the rendering provider can use his or her NPI in boxes 17 and 17b if they first take every step necessary to obtain the referring physician’s NPI.

Practices that find they cannot bill with their NPIs alone should contact their carriers or NPPES immediately.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For additional questions concerning this matter, contact Melesia Tillman, CCP, CPC, ACR’s practice management specialist, at (404) 633-3777, ext. 820, or [email protected].

Share: 

Filed under:Billing/CodingFrom the CollegePractice Support Tagged with:BillingCenters for Medicare & Medicaid Services (CMS)CodingNPINPPESPractice toolsrheumatology

Related Articles

    National Provider Identifier System Becomes Mandatory Next Month

    April 1, 2007

    On May 23 it will be mandatory to use your National Provider Identifier (NPI) number when billing the Centers for Medicare & Medicaid Services (CMS). Currently, you can use your PIN alone, your PIN and the new NPI, or the NPI alone—but as of May 23, only the NPI number will be accepted.

    Cutaneous Lupus Tied to Risk for Coexisting Autoimmune Conditions

    May 10, 2018

    NEW YORK (Reuters Health)—Patients with cutaneous lupus erythematosus (CLE) should be monitored closely for other autoimmune conditions, researchers suggest. Dr. Benjamin Chong, Dr. Linda Hynan and Elaine Kunzler of the University of Texas Southwestern Medical Center in Dallas analyzed data from 129 adults in the UTSW Cutaneous Lupus Registry (mean age, 49; 79% women). Individuals…

    President’s Perspective: Will the Physician Payment Sunshine Act Shed Light on Conflicts of Interest?

    July 1, 2013

    What rheumatologists should know about complying with the PPSA when it goes into effect on August 1

    How to Manage Denials of Evaluation and Management Coding for New Rheumatology Patients

    January 1, 2015

    Tips on defining new and established patients; determining an appeal approach

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences